Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.

Saved in:
Bibliographic Details
Title: Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
Authors: Jiangbo Liu1,2, Jiguang Ma3, Zheng Wu1, Wei Li1, Dong Zhang1, Liang Han1, Fengfei Wang4, Reindl, Katie M.5, Erxi Wu4, Qingyong Ma1 qyma56@mail.xjtu.edu.cn
Source: BMC Cancer. 9/20/2014, Vol. 14, p1-17. 17p. 2 Charts, 8 Graphs.
Database: Academic Search Ultimate
Description
ISSN:14712407
DOI:10.1186/1471-2407-14-686